What Is the Best Over-the-Counter Treatment for Actinic Keratosis?

No over-the-counter product can reliably clear actinic keratoses the way prescription creams and in-office procedures can. The most effective OTC strategy is actually a combination: consistent broad-spectrum sunscreen to prevent new lesions and encourage existing ones to fade, paired with oral nicotinamide (a form of vitamin B3) that has shown modest benefits in clinical trials. Beyond those two, a handful of specialized topical products carry promising but limited evidence. Understanding where the real evidence sits, and where it gets thin, can help you make better decisions before and between dermatologist visits.

How Prescription Treatments Set the Standard

To understand where OTC options stand, you first need to know what the proven prescription therapies actually achieve. Topical 5-fluorouracil (5-FU), the workhorse of at-home prescription treatment, reduced total actinic keratosis counts by about 94% in one head-to-head trial, with complete clearance in 84% of patients by 24 weeks.¹ Imiquimod, another prescription cream, reached lower clearance rates in that study but still outperforms anything available without a prescription. A more recent split-face comparison found that imiquimod 3.75% and 5-FU 4% cream cleared roughly 68–73% of lesions with no significant difference between them.² Tirbanibulin, a newer prescription option, earned a strong recommendation in the most recent American Academy of Dermatology focused update on actinic keratosis management.³

These clearance rates set a benchmark that no OTC product approaches. That does not mean OTC measures are useless, but it frames them correctly: they are preventive, supplementary, or bridge strategies rather than definitive treatments.

Sunscreen Is the Strongest OTC Measure

If you are looking for the single best thing you can buy without a prescription, it is a good broad-spectrum sunscreen with an SPF of at least 30. That may sound underwhelming, but the evidence behind daily sunscreen use for actinic keratoses is stronger than the evidence behind any OTC cream, serum, or supplement marketed specifically for the condition.

A randomized trial in Australia assigned over 400 people to daily sunscreen or a base cream with no UV filters. The sunscreen group developed roughly 38% fewer new actinic keratoses, and existing lesions were significantly more likely to resolve on their own. There was also a clear dose-response pattern: the more sunscreen a person used, the fewer new lesions appeared and the more old ones faded.⁴ That last point matters, because casual or sporadic use does not deliver the same benefit. You need to apply it every day, even on cloudy days, even in winter if you spend time outdoors.

The practical implication: before spending money on specialty creams or supplements, make sure your sunscreen game is solid. Reapply every two hours during sustained sun exposure, and use enough of it. Most people apply less than half the amount used in sunscreen studies, which cuts the real-world SPF dramatically.

Nicotinamide Supplements

Nicotinamide, also sold as niacinamide, is a form of vitamin B3 available cheaply at any pharmacy. It works by boosting cellular energy production and supporting DNA repair after UV damage. A large randomized trial gave 500 mg of nicotinamide twice daily to people with a history of at least two non-melanoma skin cancers and found that actinic keratosis counts were 11% lower than placebo at three months and up to 20% lower at nine months.⁵

That sounds promising, and dermatologists frequently recommend nicotinamide to high-risk patients. But the picture is more complicated than a single trial suggests. A systematic review and meta-analysis pooling data from three trials found no statistically significant difference in actinic keratosis counts between nicotinamide and control groups overall, and rated the quality of evidence as very low because of inconsistency and imprecision across the studies. The same review did note that nicotinamide was associated with a significant reduction in actual skin cancers across those trials, which is arguably the more important outcome.⁶

The takeaway is that nicotinamide is safe, inexpensive, and has a reasonable chance of slowing actinic keratosis development, but it is not going to clear existing patches. Think of it as a supplement to reduce future risk, not a treatment for lesions you already have. It also does not replace sunscreen, and importantly, the benefit appears to stop when you stop taking it.

Photolyase-Based Sunscreens

A newer category of products combines UV filters with photolyase, a DNA-repair enzyme derived from a marine organism. These are sold as medical-device sunscreens in Europe and are available in some markets online. The idea is that photolyase repairs a specific type of UV-induced DNA damage (cyclobutane pyrimidine dimers) that standard sunscreens prevent but cannot reverse once formed.

A real-world study of patients with skin phototypes III–IV (medium to olive complexions) who applied a photolyase-based product with SPF 100+ daily for six months found that about 26% of their actinic keratosis lesions disappeared completely, with statistically significant improvements in clinical severity scores.⁷ A broader review covering over 200 patients treated with one commercial photolyase product concluded that the evidence supports its use for managing actinic keratosis in the context of field cancerization, meaning widespread sun damage across an area of skin rather than isolated spots.⁸

These products are not widely stocked at your average drugstore, and the studies so far have been relatively small and often industry-supported. Still, the results are encouraging enough that some dermatologists recommend them as a daily sunscreen upgrade for patients managing field cancerization. The practical limitation is availability and cost: they tend to be significantly more expensive than ordinary sunscreens.

Antioxidant Serums With Vitamin C, E, and Ferulic Acid

Topical antioxidant serums are not marketed as actinic keratosis treatments, but they address the underlying UV damage that drives the condition. A combination of vitamin C, vitamin E, and ferulic acid has been studied specifically for its photoprotective effects on human skin. In laboratory and clinical testing, this combination provided meaningful protection against UV-induced sunburn cells, DNA damage (thymine dimers), and immune suppression caused by UV exposure.⁹ Another study confirmed that the same vitamin C and E combination stabilized by ferulic acid provided significant photoprotection across multiple evaluation methods.¹⁰

The original research establishing this combination found that adding ferulic acid to vitamins C and E doubled the photoprotection compared to vitamins C and E alone, and that the combination provided synergistic protection against oxidative stress relevant to photoaging and skin cancer.¹¹

To be clear, none of these studies tested whether antioxidant serums clear existing actinic keratoses. What they show is that applied under sunscreen in the morning, these formulations add a layer of UV defense that sunscreen alone does not fully provide. For someone already managing actinic keratoses, this is a reasonable addition to a daily sunscreen routine, though it sits firmly in the “prevention and damage reduction” category rather than the “treatment” category. The serums can be pricey, and formulation quality varies widely between brands. Look for products that keep vitamin C in a stable, low-pH form (typically L-ascorbic acid at 10–20%) and include both vitamin E and ferulic acid.

Birch Bark Extract and Betulin

One of the more intriguing but still early-stage OTC-adjacent options involves betulin, a compound found in birch bark. A pilot study tested birch bark ointment on actinic keratoses and found that 79% of patients treated with the ointment alone achieved clearance of more than 75% of their lesions, and when combined with cryotherapy, the response rate rose to 93%.¹² A subsequent randomized pilot study using a refined betulin-based oleogel confirmed that the product was well tolerated and achieved 100% clearance in 64% of patients after three months, compared to 79% for cryotherapy.¹³ Histological analysis in that study showed reduced cellular abnormality in the skin after treatment. Laboratory work on the birch bark extract demonstrated dose-dependent cytotoxic effects on abnormal cells, providing a plausible biological mechanism.¹⁴

These are genuinely interesting results. The catch is that both clinical studies were small pilots, not the kind of large randomized trials that would change treatment guidelines. Betulin-based products exist in some European markets as wound-healing ointments, and you can find birch bark extract in specialty skincare, but no major dermatology society recommends them as a standard treatment. If you already have mild actinic keratoses and want to try something while waiting for a dermatology appointment, this is worth knowing about, but it would be premature to rely on it in place of proven therapies.

Keratolytics as a Supporting Step

You may have noticed that actinic keratoses feel rough, scaly, and sometimes crusty. That thickened surface layer can actually interfere with the penetration of any topical product, whether prescription or OTC. Keratolytic agents, substances that soften and remove that dead skin layer, can improve the results of whatever else you are applying. Urea cream (typically 20–40%), salicylic acid preparations, and topical retinoids all fall into this category and are available without a prescription.

These products do not treat actinic keratosis on their own. Their role is to thin the thickened skin and improve absorption of active treatments. If you are using a prescription cream like 5-FU or imiquimod, pretreatment with a keratolytic can improve response rates. If you are relying on OTC products like a photolyase sunscreen or an antioxidant serum, the same logic applies: getting the dead skin out of the way lets the active ingredients reach where they need to go. Urea cream at 20% or higher is inexpensive and widely available. Apply it once daily for a week or two before starting a treatment regimen, and your results with the active treatment may be noticeably better.

Why Actinic Keratoses Deserve Attention

It is easy to dismiss rough, dry patches on sun-exposed skin as a cosmetic annoyance. They are not. A large Swedish cohort study following over 17,000 patients with actinic keratosis for ten years found that these individuals had roughly five times the overall risk of developing skin cancer compared to people without actinic keratoses. The risk was particularly elevated for squamous cell carcinoma, where the hazard ratio reached about 7.7.¹⁵ Some individual lesions will never progress, and dermatologists cannot reliably predict which ones will. That uncertainty is exactly why treatment is recommended rather than watchful waiting for most patients.

The economic burden is substantial as well. Actinic keratosis management was estimated to cost over $1.2 billion annually in direct medical costs in the United States, driven mainly by physician visits and procedures.¹⁶ That scale hints at how common this condition is and how many people cycle through repeat treatments. Anything you can do to reduce new lesion formation between dermatologist visits, including the OTC measures covered here, has real practical value.

When OTC Approaches Are Not Enough

There are situations where relying on OTC products is genuinely risky rather than merely suboptimal. If you are immunocompromised, whether from organ transplant medications, long-term corticosteroids, or other immunosuppressive therapies, actinic keratoses behave more aggressively. An expert panel review found that immunocompromised patients tend to have more advanced presentations and a higher risk of skin cancers arising from their lesions, making the lesions harder to treat and outcomes worse overall.¹⁷ Certain medications compound the problem further. Patients treated with the antifungal voriconazole while on immunosuppressants have a significantly higher risk of their actinic keratoses progressing to squamous cell carcinoma, and those cancers carry a worse prognosis.¹⁸

Even in otherwise healthy people, certain red flags should bypass the OTC aisle entirely. A lesion that is growing quickly, bleeding, ulcerating, or developing into a raised nodule needs a biopsy, not a cream. A patch that feels tender or looks very different from your other actinic keratoses deserves professional evaluation. And if you have extensive field cancerization, with dozens of rough spots across your scalp, forearms, or face, you are beyond the point where spot treatment with OTC products will meaningfully change the trajectory. That kind of diffuse damage calls for prescription field therapies, photodynamic therapy, or a combination approach directed by a dermatologist.

Putting Together a Practical OTC Regimen

If you have a few mild actinic keratoses, see your dermatologist regularly, and want to do everything you can between appointments, a reasonable OTC regimen draws on the evidence above:

Daily sunscreen: Broad-spectrum SPF 30 or higher, applied generously every morning and reapplied during extended outdoor time. This is the single most impactful step.
Nicotinamide: 500 mg twice daily by mouth. Cheap, safe, and supported by at least one large trial, even if the pooled evidence is not as consistent as you’d want.
Antioxidant serum: A vitamin C, vitamin E, and ferulic acid formulation applied under sunscreen each morning to add photoprotective benefit.
Keratolytic prep: A 20–40% urea cream applied to rough patches for a week or two before starting any active topical treatment, or before a dermatology visit where field therapy is planned.

Photolyase-based sunscreens can replace or supplement your regular sunscreen if you can find and afford them. Birch bark or betulin products are worth watching as the research matures, but they are not yet well enough studied to anchor a regimen around.

None of these measures substitute for periodic skin checks or for prescription treatment when your dermatologist recommends it. The best role for OTC strategies is reducing the number and severity of lesions that develop between professional treatments, essentially buying time and lowering the burden on the treatments that actually clear lesions.

Common Misconceptions About OTC Actinic Keratosis Products

A few myths circulate online that are worth addressing directly. One is that apple cider vinegar or other household acids can “burn off” actinic keratoses at home. There are no controlled studies supporting this, and self-treating with caustic substances risks chemical burns, scarring, and missing a lesion that has already progressed to cancer. A second misconception is that high-dose vitamin A supplements can treat or reverse actinic keratoses. While topical retinoids (which are prescription-strength vitamin A derivatives) can be used as adjunctive therapy, oral vitamin A megadoses carry toxicity risks and have not demonstrated clear benefit for existing lesions in well-designed trials.

A third persistent idea is that once an actinic keratosis fades or feels smooth, it is gone for good. In reality, these lesions can recur in the same location, and the underlying sun damage in the surrounding skin remains. The field cancerization concept is important here: it means the visible rough spots are just the tips of the iceberg, and the skin around them has subclinical damage that can produce new lesions at any time. That is exactly why ongoing prevention with sunscreen and nicotinamide matters even after a successful round of treatment.